Investing
Editor's Top Picks
Your one-stop resource for personal news and tips.
More form Investing
UBS expects to complete Credit Suisse acquisition as early as June 12
UBS Group said it expects to complete its acquisition of Swiss peer Credit Suisse Group…
UBS Expects to Complete Credit Suisse Acquisition, Delisting as Early as Next Week – Update
By Pierre Bertrand UBS Group said it expects to complete its acquisition of Credit Suisse…
Novo Nordisk In Talks to Buy Biocorp in EUR154 Mln Deal
By Dominic Chopping Danish pharmaceutical company Novo Nordisk said Monday it has entered into exclusive…
Evolution Extends Lives of Two Mines, Restructures Debt
By Rhiannon Hoyle Evolution Mining on Monday said it has extended the lives of two…
Doctor Care Anywhere Agrees to Sell Australian Subsidiary for A$3M
By Stuart Condie SYDNEY--Telehealth provider Doctor Care Anywhere agreed to sell the Australia unit it…
Elders CEO, MD Mark Allison Postpones His Planned Retirement
By Stuart Condie SYDNEY--Elders Chief Executive and Managing Director Mark Allison postponed his retirement after…
U.S. stocks appear headed for a flat open, but keep an eye peeled Monday for Dish, Gannett, Palo Alto Networks, CarGurus and others
Here are some prospective movers to keep an eye on Monday, when the U.S. stock…
A Fed skip? Pause? Either way, investors aren’t likely out of the woods yet.
Maybe not. Even if the Federal Reserve skips an interest-rate hike at its June 13-14…
Big Tech is driving corporate earnings, and buoying expectations for coming months
Heading into first-quarter earnings, Wall Street expected a bumpy ride. But Big Tech’s rebound helped…
Picking the Right Accounting Method Is Key for Tax-Loss Harvesting
When the stock and bond markets melted down last year, many investors learned a painful…
Amazon Taking on AT&T and Verizon? Unlikely.
Telecom stocks got clobbered on Friday following a Bloomberg story that said Amazon was holding…
Housing Ended Spring With a Whimper. What’s Next for Prices, Mortgage Rates.
This spring was a challenging one for prospective buyers. This summer might not be any…
Many Biotechs Are Worth More Dead Than Alive
Atea Pharmaceuticals, a biotech working to develop antiviral treatments for Covid-19 and hepatitis C, might…
Opinion: Technically speaking, a new bull market started last October. Buy on weakness.
We’re seven months into a new U.S. bull market, and weakness is to be bought.…
Target’s stock snaps longest losing streak in 23 years as anti-LGBTQ+ backlash continues
Target Corp.’s stock is up 0.1% Friday after snapping its longest losing streak in 23…